Only 9% want medical treatments decided by MPs
Public wants politics left out of treatment decision, says survey. Decisions on NHS treatments should be made by clinicians, public representatives and managers - and not politicians, according to a MORI poll for the NHS Confederation. Asked which groups people felt should decide on the availability of NHS medicines 70 per cent said clinicians. Just 9 per cent thought MPs should make judgements, while 6 per cent thought councillors should be involved.
The poll also asked what factors members of the public thought should influence decisions.
Half of the respondents thought the effectiveness of treatment was the most important factor, while 38 per cent said whether the treatment would be used to treat a life threatening condition should be taken into consideration.
Of the 969 polled, just 22 per cent said cost of treatment should be taken into account. Eighteen per cent thought local trusts should consider whether other treatments would have to be withdrawn as a result.
However, the poll did not ask directly whether ministers should be involved, despite the health secretary last year urging primary care trusts not to restrict the cancer drug Herceptin, before it was approved by the National Institute for Health and Clinical Excellence.
From:
http://www.hsj.co.uk/healthservicejournal/pages/n1/p9/070125
The poll of 969 members of the public, conducted by Ipsos MORI, asked which groups should make decisions about which medicines are funded by their local NHS. Respondents were given a list of six groups to choose from.
Only one in 11 (9 per cent) think MPs should be part of the decision making process. Even less people (6 per cent) think local councillors should have a say.
On average respondents opted for a combination of two groups to make decisions about the funding of treatments. Unsurprisingly, most people (70 per cent) think that clinicians should be involved. Patient representatives are the second favourite with 33 per cent of participants thinking they should contribute to the process.
The poll also asked what factors members of the public thought should influence decisions.
Half of the respondents thought the effectiveness of treatment was the most important factor, while 38 per cent said whether the treatment would be used to treat a life threatening condition should be taken into consideration.
Of the 969 polled, just 22 per cent said cost of treatment should be taken into account. Eighteen per cent thought local trusts should consider whether other treatments would have to be withdrawn as a result.
However, the poll did not ask directly whether ministers should be involved, despite the health secretary last year urging primary care trusts not to restrict the cancer drug Herceptin, before it was approved by the National Institute for Health and Clinical Excellence.
From:
http://www.hsj.co.uk/healthservicejournal/pages/n1/p9/070125
The poll of 969 members of the public, conducted by Ipsos MORI, asked which groups should make decisions about which medicines are funded by their local NHS. Respondents were given a list of six groups to choose from.
Only one in 11 (9 per cent) think MPs should be part of the decision making process. Even less people (6 per cent) think local councillors should have a say.
On average respondents opted for a combination of two groups to make decisions about the funding of treatments. Unsurprisingly, most people (70 per cent) think that clinicians should be involved. Patient representatives are the second favourite with 33 per cent of participants thinking they should contribute to the process.
posted by Dr Search- Principal Consultant at the Search Clinic at
8:41 AM
0 Comments:
Post a Comment
<< Home